ASBMB Annual Meeting

Gingras studies proteomics’ implications for research

She will present her work at the ASBMB 2020 annual meeting Molecular & Cellular Proteomics session
Adriana Bankston
March 6, 2020

When Anne-Claude Gingras was working on her Ph.D. in Nahum Sonenberg’s lab at McGill University, she focused on the regulation of the protein synthesis machinery by phosphorylation. Her thesis described the role of the mechanistic target of rapamycin complex in phosphorylating a translational inhibitor.

The ASBMB annual meeting at EB has been canceled. This decision comes as COVID-19 spreads, institutions restrict travel and jurisdictions declare states of emergency. Read the letter sent to attendees.
Gingras-Anne-Claude-300x300.jpg
Anne-Claude Gingras

Curious about the unexplored protein phosphatase components of phosphoregulation, Gingras realized that then-emerging proteomics technologies would be key to solving this puzzle. She moved to Seattle to study mass spectrometry with Ruedi Aebersold, and there she improved methods for protein–protein interaction detection. She started her own research group in late 2005.

Gingras now runs a signal transduction, systems biology and proteomics lab at the Lunenfeld–Tanenbaum Research Institute in Toronto. Her team works to improve experimental and computational approaches for interaction proteomics. Misregulation of protein phosphorylation is implicated in numerous diseases, including cancer and diabetes, so she applies these techniques to identify and understand new components of signaling pathways related to these pathologies. More recently, she began systematically applying the proximity-dependent biotinylation approach BioID to study the composition and organization of membraneless organelles and, ultimately, of human cells.

Her group’s success in defining new biological complexes and pathways implicated in disease heavily relies on the contributions of talented students, fellows and research assistants with diverse expertise in biochemistry, cell biology, mass spectrometry and bioinformatics, as well as a large network of key scientific collaborators.

Her Ph.D. and postdoc advisors shaped not only her scientific directions but also how she interacts with other scientists, Gingras said. She is committed to sharing data, methods, reagents and protocols and to helping other scientists realize their objectives. Her motto, she said, is “Science works much faster when you help one another.”

Tools for studying proteomics changes in organelles

To determine where proteins are in a cell, Anne-Claude Gingras’ group uses mass spectrometry as a high-resolution discovery-based microscope. They employ a technique known as BioID that reports on the proximity of a protein to another used as bait.

Her student Christopher Go created 200 stable cell lines that each express one organelle marker as a probe and performed proximity-dependent biotinylation to identify the composition of each organelle. Research associate James Knight then developed computational tools to analyze and visualize the data. This project revealed new addresses for many unexplored proteins and showed proteins that are at contact interfaces between organelles. The resulting paper has been published as a preprint in bioRxiv.

Using this work as a reference map, others in the Gingras lab are creating sensors to report on proteomic changes in an organelle after perturbations such as drug treatment, various growth conditions and genetic modulation with CRISPR. In profiling the surface of the lysosome, postdoctoral fellow Geoffrey Hesketh found a new pathway that activates the mechanistic target of rapamycin complex by extracellular protein through the process of macropinocytosis. This work has implications for disease in which macropinocytosis is activated, such as Ras-dependent cancers.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Adriana Bankston

Adriana Bankston is a senior fellow in science policy at the Federation of American Scientists. She is also strategic advisor at the Journal of Science Policy and Governance.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.